Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2020 Jun 4

PMID 32485957

Citations 30

Authors

Zhongyu Liu

Justin D Anderson

Lily Deng

Stephen Mackay

Johnathan Bailey

Latona Kersh

Steven M Rowe

Jennifer S Guimbellot

Affiliations

Soon will be listed here.

Abstract

We describe a human nasal epithelial (HNE) organoid model derived directly from patient samples that is well-differentiated and recapitulates the airway epithelium, including the expression of cilia, mucins, tight junctions, the cystic fibrosis transmembrane conductance regulator (CFTR), and ionocytes. This model requires few cells compared to airway epithelial monolayer cultures, with multiple outcome measurements depending on the application. A novel feature of the model is the predictive capacity of lumen formation, a marker of baseline CFTR function that correlates with short-circuit current activation of CFTR in monolayers and discriminates the cystic fibrosis (CF) phenotype from non-CF. Our HNE organoid model is amenable to automated measurements of forskolin-induced swelling (FIS), which distinguishes levels of CFTR activity. While the apical side is not easily accessible, RNA- and DNA-based therapies intended for systemic administration could be evaluated in vitro, or it could be used as an ex vivo biomarker of successful repair of a mutant gene. In conclusion, this highly differentiated airway epithelial model could serve as a surrogate biomarker to assess correction of the mutant gene in CF or other diseases, recapitulating the phenotypic and genotypic diversity of the population.

Citing Articles

Comparison of characteristics and immune responses between paired human nasal and bronchial epithelial organoids.

Zhu L, Yang W, Luo J, Lu D, Hu Y, Zhang R Cell Biosci. 2025; 15(1):18.

PMID: 39920853 PMC: 11806626. DOI: 10.1186/s13578-024-01342-1.

Human Induced Lung Organoids: A Promising Tool for Cystic Fibrosis Drug Screening.

Demchenko A, Balyasin M, Nazarova A, Grigorieva O, Panchuk I, Kondrateva E Int J Mol Sci. 2025; 26(2).

PMID: 39859153 PMC: 11764749. DOI: 10.3390/ijms26020437.

Nondestructive, quantitative viability analysis of 3D tissue cultures using machine learning image segmentation.

Trettner K, Hsieh J, Xiao W, Lee J, Armani A APL Bioeng. 2024; 8(1):016121.

PMID: 38566822 PMC: 10985731. DOI: 10.1063/5.0189222.

Adult Animal Stem Cell-Derived Organoids in Biomedical Research and the One Health Paradigm.

Gabriel V, Zdyrski C, Sahoo D, Ralston A, Wickham H, Bourgois-Mochel A Int J Mol Sci. 2024; 25(2).

PMID: 38255775 PMC: 10815683. DOI: 10.3390/ijms25020701.

Laboratory Tools to Predict CFTR Modulator Therapy Effectiveness and to Monitor Disease Severity in Cystic Fibrosis.

Bacalhau M, Camargo M, Lopes-Pacheco M J Pers Med. 2024; 14(1).

PMID: 38248793 PMC: 10820563. DOI: 10.3390/jpm14010093.

References

Mosler K, Coraux C, Fragaki K, Zahm J, Bajolet O, Bessaci-Kabouya K . Feasibility of nasal epithelial brushing for the study of airway epithelial functions in CF infants. J Cyst Fibros. 2007; 7(1):44-53. DOI: 10.1016/j.jcf.2007.04.005. View

Avramescu R, Kai Y, Xu H, Bidaud-Meynard A, Schnur A, Frenkiel S . Mutation-specific downregulation of CFTR2 variants by gating potentiators. Hum Mol Genet. 2017; 26(24):4873-4885. PMC: 5886047. DOI: 10.1093/hmg/ddx367. View

Birket S, Chu K, Liu L, Houser G, Diephuis B, Wilsterman E . A functional anatomic defect of the cystic fibrosis airway. Am J Respir Crit Care Med. 2014; 190(4):421-32. PMC: 4214131. DOI: 10.1164/rccm.201404-0670OC. View

Liu L, Chu K, Houser G, Diephuis B, Li Y, Wilsterman E . Method for quantitative study of airway functional microanatomy using micro-optical coherence tomography. PLoS One. 2013; 8(1):e54473. PMC: 3553101. DOI: 10.1371/journal.pone.0054473. View

Muller L, Brighton L, Carson J, Fischer 2nd W, Jaspers I . Culturing of human nasal epithelial cells at the air liquid interface. J Vis Exp. 2013; (80). PMC: 3938966. DOI: 10.3791/50646. View

Chu K, Unglert C, Ford T, Cui D, Carruth R, Singh K . In vivo imaging of airway cilia and mucus clearance with micro-optical coherence tomography. Biomed Opt Express. 2016; 7(7):2494-505. PMC: 4948609. DOI: 10.1364/BOE.7.002494. View

Tuggle K, Birket S, Cui X, Hong J, Warren J, Reid L . Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats. PLoS One. 2014; 9(3):e91253. PMC: 3946746. DOI: 10.1371/journal.pone.0091253. View

Dekkers J, Berkers G, Kruisselbrink E, Vonk A, De Jonge H, Janssens H . Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis. Sci Transl Med. 2016; 8(344):344ra84. DOI: 10.1126/scitranslmed.aad8278. View

Wojtkowski M, Srinivasan V, Ko T, Fujimoto J, Kowalczyk A, Duker J . Ultrahigh-resolution, high-speed, Fourier domain optical coherence tomography and methods for dispersion compensation. Opt Express. 2009; 12(11):2404-22. DOI: 10.1364/opex.12.002404. View

10.

Bell S, De Boeck K, Amaral M . New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls. Pharmacol Ther. 2014; 145:19-34. DOI: 10.1016/j.pharmthera.2014.06.005. View

11.

Huang W, Zhao H, Dong H, Wu Y, Yao L, Zou F . High-mobility group box 1 impairs airway epithelial barrier function through the activation of the RAGE/ERK pathway. Int J Mol Med. 2016; 37(5):1189-98. PMC: 4829140. DOI: 10.3892/ijmm.2016.2537. View

12.

Brewington J, Filbrandt E, LaRosa 3rd F, Ostmann A, Strecker L, Szczesniak R . Detection of CFTR function and modulation in primary human nasal cell spheroids. J Cyst Fibros. 2017; 17(1):26-33. PMC: 5868354. DOI: 10.1016/j.jcf.2017.06.010. View

13.

Derichs N . Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis. Eur Respir Rev. 2013; 22(127):58-65. PMC: 9487424. DOI: 10.1183/09059180.00008412. View

14.

Schogler A, Blank F, Brugger M, Beyeler S, Tschanz S, Regamey N . Characterization of pediatric cystic fibrosis airway epithelial cell cultures at the air-liquid interface obtained by non-invasive nasal cytology brush sampling. Respir Res. 2017; 18(1):215. PMC: 5745630. DOI: 10.1186/s12931-017-0706-7. View

15.

Pedersen P, Braunstein T, Jorgensen A, Larsen P, Holstein-Rathlou N, Frederiksen O . Stimulation of aquaporin-5 and transepithelial water permeability in human airway epithelium by hyperosmotic stress. Pflugers Arch. 2006; 453(6):777-85. DOI: 10.1007/s00424-006-0157-3. View

16.

Bertoncini E, Colomb-Lippa D . Pulmonology: CFTR modulators for cystic fibrosis. JAAPA. 2013; 26(2):59-60. DOI: 10.1097/01720610-201302000-00013. View

17.

de Courcey F, Zholos A, Atherton-Watson H, Williams M, Canning P, Danahay H . Development of primary human nasal epithelial cell cultures for the study of cystic fibrosis pathophysiology. Am J Physiol Cell Physiol. 2012; 303(11):C1173-9. DOI: 10.1152/ajpcell.00384.2011. View

18.

Moonwiriyakit A, Koval M, Muanprasat C . Pharmacological stimulation of G-protein coupled receptor 40 alleviates cytokine-induced epithelial barrier disruption in airway epithelial Calu-3 cells. Int Immunopharmacol. 2019; 73:353-361. PMC: 6620115. DOI: 10.1016/j.intimp.2019.05.026. View

19.

Heijerman H, McKone E, Downey D, Van Braeckel E, Rowe S, Tullis E . Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial. Lancet. 2019; 394(10212):1940-1948. PMC: 7571408. DOI: 10.1016/S0140-6736(19)32597-8. View

20.

Dekkers J, Wiegerinck C, De Jonge H, Bronsveld I, Janssens H, de Winter-de Groot K . A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nat Med. 2013; 19(7):939-45. DOI: 10.1038/nm.3201. View